Who owns Galecto Biotech?

Galecto Biotech is currently owned by Seventure Partners, through Quadrivium 1 Seed Fund, since 2018.

When did Seventure Partners acquire Galecto Biotech?

Seventure Partners acquired Galecto Biotech in 2018 (active for 8 years).

Home/Companies/Healthcare/Galecto Biotech

Galecto Biotech

Healthcare·

Denmark·Active·8yr hold

Galecto Biotech is a healthcare company, headquartered in Denmark.

Entry

2018

Hold

8yr

Status

Active

Est. EV

–

Investor

Seventure Partners

Key facts

HQDenmark

SectorHealthcare

Galecto Biotech is a biotech/healthcare company developing innovative therapies and diagnostics.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Quadrivium 1 Seed Fund

Other portfolio companies in the same fund.

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.

Last updated April 2026 · Sourced from public filings